Crescent Capital BDC, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crescent Capital BDC, Inc. (CCAP) on November 18, 2021. The filing reports a significant capital raising event involving the issuance of common stock pursuant to a Purchase Agreement dated November 15, 2021.
Key Financial Metrics
- Shares Issued: 2,500,000 shares of common stock.
- Offering Price: $21.33 per share.
- Net Proceeds: Approximately $52.8 million (after estimated offering expenses).
- Over-Allotment Option: Underwriters granted an option to purchase an additional 375,000 shares, exercisable for 30 days.
- Underwriting Costs: The Company's investment adviser, Crescent Cap Advisors, LLC, paid the supplemental payment and sales load to the underwriters. The Company is not obligated to repay these amounts.
Note: This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes
The primary material change is the increase in outstanding common stock and the infusion of approximately $52.8 million in net capital. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing does not contain updated guidance, outlook, or management commentary regarding future performance. It references the full text of the Purchase Agreement (Exhibit 1.1) for complete terms. No specific risks or contingencies are detailed in this summary section of the 8-K.
Key Facts for Investor Verification
- Verify the final number of shares issued if the 375,000 share over-allotment option is exercised within the 30-day window.
- Confirm the exact amount of net proceeds after final settlement of offering expenses.
- Review the full Purchase Agreement (Exhibit 1.1) for specific covenants or conditions attached to the capital raise.
- Check subsequent filings for the impact of this capital raise on the Company's leverage ratios and dividend coverage.